CA2224970A1 - Procede de detection de cellules solides cancereuses et d'heterotypie histologique et procede d'examen du tissu dans le but d'effectuer une transplantation de moelle osseuse et une transplantation de cellules souches du sang peripherique - Google Patents

Procede de detection de cellules solides cancereuses et d'heterotypie histologique et procede d'examen du tissu dans le but d'effectuer une transplantation de moelle osseuse et une transplantation de cellules souches du sang peripherique

Info

Publication number
CA2224970A1
CA2224970A1 CA002224970A CA2224970A CA2224970A1 CA 2224970 A1 CA2224970 A1 CA 2224970A1 CA 002224970 A CA002224970 A CA 002224970A CA 2224970 A CA2224970 A CA 2224970A CA 2224970 A1 CA2224970 A1 CA 2224970A1
Authority
CA
Canada
Prior art keywords
cancer cells
solid cancer
bone marrow
transplantation
peripheral blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002224970A
Other languages
English (en)
Other versions
CA2224970C (fr
Inventor
Haruo Sugiyama
Kazushi Inoue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2224970A1 publication Critical patent/CA2224970A1/fr
Application granted granted Critical
Publication of CA2224970C publication Critical patent/CA2224970C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
CA002224970A 1996-04-16 1997-04-15 Procede de detection de cellules solides cancereuses et d'heterotypie histologique et procede d'examen du tissu dans le but d'effectuer une transplantation de moelle osseuse et une transplantation de cellules souches du sang peripherique Expired - Lifetime CA2224970C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP9405096 1996-04-16
JP9405196 1996-04-16
JP8/94051 1996-04-16
JP8/94050 1996-04-16
JP8/95427 1996-04-17
JP9542796 1996-04-17
PCT/JP1997/001300 WO1997039354A1 (fr) 1996-04-16 1997-04-15 Procede de detection de cellules solides cancereuses et d'heterotypie histologique et procede d'examen du tissu dans le but d'effectuer une transplantation de moelle osseuse et une transplantation de cellules souches du sang peripherique

Publications (2)

Publication Number Publication Date
CA2224970A1 true CA2224970A1 (fr) 1997-10-23
CA2224970C CA2224970C (fr) 2002-04-02

Family

ID=27307463

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002224970A Expired - Lifetime CA2224970C (fr) 1996-04-16 1997-04-15 Procede de detection de cellules solides cancereuses et d'heterotypie histologique et procede d'examen du tissu dans le but d'effectuer une transplantation de moelle osseuse et une transplantation de cellules souches du sang peripherique

Country Status (10)

Country Link
US (1) US6225051B1 (fr)
EP (1) EP0846949B1 (fr)
JP (1) JP3122771B2 (fr)
KR (1) KR100262838B1 (fr)
AT (1) ATE298887T1 (fr)
CA (1) CA2224970C (fr)
DE (1) DE69733629T2 (fr)
ES (1) ES2242221T3 (fr)
TW (1) TW562928B (fr)
WO (1) WO1997039354A1 (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4789095B2 (ja) 1997-07-16 2011-10-05 治夫 杉山 ウイルムス腫瘍遺伝子（ｗｔ１）に対する発現阻害物質を含んで成る固形腫瘍治療剤
US6693033B2 (en) 2000-02-10 2004-02-17 Motorola, Inc. Method of removing an amorphous oxide from a monocrystalline surface
CA2404431C (fr) 2000-03-27 2011-06-07 Thomas Jefferson University Guanylyl cyclase c servant a deceler les cancers de l'estomac et de l'oesophage
JP3846199B2 (ja) 2000-05-24 2006-11-15 治夫 杉山 Ｗｔ１関連疾患の検査方法
WO2002003437A1 (fr) * 2000-06-30 2002-01-10 Motorola, Inc., A Corporation Of The State Of Delaware Structure et dispositif de semi-conducteur hybride
US6555946B1 (en) 2000-07-24 2003-04-29 Motorola, Inc. Acoustic wave device and process for forming the same
US6638838B1 (en) 2000-10-02 2003-10-28 Motorola, Inc. Semiconductor structure including a partially annealed layer and method of forming the same
US6673646B2 (en) 2001-02-28 2004-01-06 Motorola, Inc. Growth of compound semiconductor structures on patterned oxide films and process for fabricating same
US6709989B2 (en) 2001-06-21 2004-03-23 Motorola, Inc. Method for fabricating a semiconductor structure including a metal oxide interface with silicon
US6531740B2 (en) 2001-07-17 2003-03-11 Motorola, Inc. Integrated impedance matching and stability network
US6646293B2 (en) 2001-07-18 2003-11-11 Motorola, Inc. Structure for fabricating high electron mobility transistors utilizing the formation of complaint substrates
US6693298B2 (en) 2001-07-20 2004-02-17 Motorola, Inc. Structure and method for fabricating epitaxial semiconductor on insulator (SOI) structures and devices utilizing the formation of a compliant substrate for materials used to form same
US6667196B2 (en) 2001-07-25 2003-12-23 Motorola, Inc. Method for real-time monitoring and controlling perovskite oxide film growth and semiconductor structure formed using the method
US6639249B2 (en) 2001-08-06 2003-10-28 Motorola, Inc. Structure and method for fabrication for a solid-state lighting device
US6589856B2 (en) 2001-08-06 2003-07-08 Motorola, Inc. Method and apparatus for controlling anti-phase domains in semiconductor structures and devices
US6673667B2 (en) 2001-08-15 2004-01-06 Motorola, Inc. Method for manufacturing a substantially integral monolithic apparatus including a plurality of semiconductor materials
WO2003020899A2 (fr) * 2001-08-31 2003-03-13 Diadexus, Inc. Compositions et methodes relatives a des genes et proteines specifiques des poumons
US20040043950A1 (en) * 2002-01-03 2004-03-04 Board Of Regents, The University Of Texas System WT1 antisense oligos for the inhibition of breast cancer
ES2478446T3 (es) * 2003-06-27 2014-07-22 International Institute Of Cancer Immunology, Inc. Método de selección de pacientes candidatos para la vacuna contra WT1
JP5165890B2 (ja) * 2004-03-29 2013-03-21 治夫 杉山 ＷＴ１遺伝子の発現を抑制するｓｉＲＮＡおよびその利用
JP4762133B2 (ja) * 2004-03-29 2011-08-31 治夫 杉山 Ｗｔ１遺伝子の発現を抑制するマイクロｒｎａおよびその利用
EP1657250A1 (fr) * 2004-11-11 2006-05-17 Charité - Universitätsmedizin Berlin Lymphocyte T épitope de WT1 qui se lie à HLA-A *01
DK2402758T3 (da) 2005-09-19 2014-11-03 Janssen Diagnostics Llc Fremgangsmåder og anvendelser til identificering af oprindelsen af et karcinom med ukendt primær oprindelse
US8338109B2 (en) 2006-11-02 2012-12-25 Mayo Foundation For Medical Education And Research Predicting cancer outcome
EP3173480A3 (fr) 2007-03-05 2017-08-16 International Institute of Cancer Immunology, Inc. Gène du récepteur des lymphocytes t spécifiques de l'antigène du cancer, peptide codé par le gène et utilisation de ceux-ci
EP2806054A1 (fr) 2008-05-28 2014-11-26 Genomedx Biosciences Inc. Systèmes et procédés de discrimination basés sur l'expression d'états pathologiques cliniques distincts dans le cancer de la prostate
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
US8669057B2 (en) 2009-05-07 2014-03-11 Veracyte, Inc. Methods and compositions for diagnosis of thyroid conditions
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
EP3323833B1 (fr) 2011-04-01 2019-12-04 Memorial Sloan-Kettering Cancer Center Anticorps bispécifiques de type récepteur de cellules t spécifiques d'un peptide wt1 présenté par hla-a2
US9803246B2 (en) 2011-06-28 2017-10-31 International Institute Of Cancer Immunology, Inc. Receptor gene for peptide cancer antigen-specific T cell
AU2012352153B2 (en) 2011-12-13 2018-07-26 Veracyte, Inc. Cancer diagnostics using non-coding transcripts
AU2013302365B2 (en) 2012-08-16 2019-03-21 Mayo Foundation For Medical Education And Research Cancer diagnostics using biomarkers
EP2968988A4 (fr) 2013-03-14 2016-11-16 Allegro Diagnostics Corp Procédés d'évaluation de l'état d'une maladie pulmonaire obstructive chronique (copd)
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
JP7356788B2 (ja) 2014-11-05 2023-10-05 ベラサイト インコーポレイテッド 機械学習および高次元転写データを使用して経気管支生検における特発性肺線維症を診断するシステムおよび方法
WO2018039490A1 (fr) 2016-08-24 2018-03-01 Genomedx Biosciences, Inc. Utilisation de signatures génomiques en vue d'une prédiction de la réactivité de patients atteints d'un cancer de la prostate à une radiothérapie postopératoire
WO2018132916A1 (fr) 2017-01-20 2018-07-26 Genomedx Biosciences, Inc. Sous-typage moléculaire, pronostic et traitement du cancer de la vessie
CA3055925A1 (fr) 2017-03-09 2018-09-13 Decipher Biosciences, Inc. Sous-typage du cancer de la prostate pour predire la reponse a une therapie hormonale
AU2018266733A1 (en) 2017-05-12 2020-01-16 Veracyte, Inc. Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622835A (en) 1994-04-28 1997-04-22 The Wistar Institute Of Anatomy & Biology WT1 monoclonal antibodies

Also Published As

Publication number Publication date
US6225051B1 (en) 2001-05-01
ATE298887T1 (de) 2005-07-15
DE69733629D1 (de) 2005-08-04
KR100262838B1 (ko) 2003-03-15
ES2242221T3 (es) 2005-11-01
DE69733629T2 (de) 2006-05-18
CA2224970C (fr) 2002-04-02
EP0846949B1 (fr) 2005-06-29
EP0846949A4 (fr) 2002-11-13
EP0846949A1 (fr) 1998-06-10
JP3122771B2 (ja) 2001-01-09
KR19990022939A (ko) 1999-03-25
TW562928B (en) 2003-11-21
WO1997039354A1 (fr) 1997-10-23

Similar Documents

Publication Publication Date Title
CA2224970A1 (fr) Procede de detection de cellules solides cancereuses et d'heterotypie histologique et procede d'examen du tissu dans le but d'effectuer une transplantation de moelle osseuse et une transplantation de cellules souches du sang peripherique
Euvrard et al. Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients
Bourhis et al. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma
EP0395642B1 (fr) Dispositif et procede servant a determiner la capacite de guerison d'un plaie incisee
GB2374872A (en) Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow
DE BERKKR et al. Quantification of regional matrix nail production
EP1035215A3 (fr) Procédé et set de sondes destinés à la détection de cancer
MXPA01003536A (es) Dispositivo de recoleccion para muestras biologicas y metodos de uso.
HK1098178A1 (en) Method for quantitative measurement of target gene expression in a fixed paraffin-embedded tissure specimens
CA2264277A1 (fr) Procedes et trousses utilises pour produire et analyser des echantillons de fluide mammaire afin de determiner des maladies du sein, dont le cancer
EP2343083A3 (fr) Procédé de sélection de patients adaptés au vaccin WT1
GB2361996A (en) Multiple marker characterization of single cells
Mizoguchi et al. Clinical, pathological, and etiologic aspects of acquired dermal melanocytosis
EP1135531A4 (fr) Methodes d'introduction de cellules heterologues chez les poissons
NZ332641A (en) method of detecting a lysosomal storage disorder by assaying the level of an enzyme, protein or peptide associated with the disease
AU1260399A (en) Method for examining kidney diseases
IL126014A0 (en) Method of killing target cells in harvested cell populations with one or more immunotoxins
Betz et al. The immunohistochemical analysis of fibronectin, collagen type III, laminin, and cytokeratin 5 in putrified skin
Eble et al. Cellular deoxyribonucleic acid content of renal oncocytomas: flow cytometric analysis of paraffin-embedded tissues from eight tumors
GB9900118D0 (en) A method for determining the temperature of a single cell in a cell sample or tissue biopsy and methods of use thereof
Hanthamrongwit et al. 5-Carboxyfluorescein diacetate as a probe for measuring the growth of keratinocytes
Tay et al. Recognition of cervical neoplasia by the estimation of a free-radical reaction product (octadeca-9, 11-dienoic acid) in exfoliated cells
Scarfì The cytokinesis-block micronucleus assay: experimental procedure and application in bioelectromagnetics research
Schanenstein et al. Significant decreases in the intensity of staining for proteins and protein thiols in basal-cell epitheliomas (basaliomas) as compared to normal skin
EP1826560A3 (fr) Procédé d'introduction de cellules hétérologues dans le poisson

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170418